au.\*:("SONSALLA, P. K")
Results 1 to 25 of 37
Selection :
The role of N-methyl-D-aspartate receptors in dopaminergic neuropathology produced by the amphetaminesSONSALLA, P. K.Drug and alcohol dependence. 1995, Vol 37, Num 2, pp 101-105, issn 0376-8716Article
The sigma receptor ligand (±)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptorsTERLECKYJ, I; SONSALLA, P. K.The Journal of pharmacology and experimental therapeutics. 1994, Vol 269, Num 1, pp 44-50, issn 0022-3565Article
The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in miceSONSALLA, P. K; HEIKKILA, R. E.European journal of pharmacology. 1986, Vol 129, Num 3, pp 339-345, issn 0014-2999Article
Modifications of the Brandel Superfusion 600 system and other revisions in superfusion technique improve the measurement of endogenous dopamine release in vitroDELLE DONNE, K. T; SONSALLA, P. K.Journal of neuroscience methods. 1996, Vol 68, Num 2, pp 289-296, issn 0165-0270Article
Deprenyl as prophylaxis against Parkinson's disease?SONSALLA, P. K; GOLBE, L. I.Clinical neuropharmacology. 1988, Vol 11, Num 6, pp 500-511, issn 0362-5664Article
Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of miceSONSALLA, P. K; HEIKKILA, R. E.Progress in neuro-psychopharmacology & biological psychiatry. 1988, Vol 12, Num 2-3, pp 345-354, issn 0278-5846Conference Paper
Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protects against methamphetamine-induced dopaminergic damage in miceSONSALLA, P. K; RIORDAN, D. E; HEIKKILA, R. E et al.The Journal of pharmacology and experimental therapeutics. 1991, Vol 256, Num 2, pp 506-512, issn 0022-3565, 7 p.Article
Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P systemSONSALLA, P. K; GIBB, J. W; HANSON, G. R et al.Neuropharmacology. 1986, Vol 25, Num 11, pp 1221-1230, issn 0028-3908Article
Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systemsSONSALLA, P. K; GIBB, J. W; HANSON, G. R et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 238, Num 3, pp 932-937, issn 0022-3565Article
Lowering ambient or core body temperature elevates striatal MPP + levels and enhances toxicity to dopamine neurons in MPTP-treated miceMOY, L. Y; ALBERS, D. S; SONSALLA, P. K et al.Brain research. 1998, Vol 790, Num 1-2, pp 264-269, issn 0006-8993Article
Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTPALBERS, D. S; ZEEVALK, G. D; SONSALLA, P. K et al.Brain research. 1996, Vol 718, Num 1-2, pp 217-220, issn 0006-8993Article
Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicitySONSALLA, P. K; NICKLAS, W. J; HEIKKILA, R. E et al.Science (Washington, D.C.). 1989, Vol 243, Num 4889, pp 398-400, issn 0036-8075Article
Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineYOUNGSTER, S. K; SONSALLA, P. K; HEIKKILA, R. E et al.Journal of neurochemistry. 1987, Vol 48, Num 3, pp 929-934, issn 0022-3042Article
Opposite responses in the striato-nigral substance P system to D1 and D2 receptor activationSONSALLA, P. K; GIBB, J. W; HANSON, G. R et al.European journal of pharmacology. 1984, Vol 105, Num 1-2, pp 185-187, issn 0014-2999Article
Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of miceGIOVANNI, A; SIEBER, B.-A; HEIKKILA, R. E et al.The Journal of pharmacology and experimental therapeutics. 1991, Vol 257, Num 2, pp 691-697, issn 0022-3565, 7 p.Article
Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's diseaseSAGE, J. I; TROOSKIN, S; SONSALLA, P. K et al.Neurology. 1990, Vol 39, Num 11, pp 60-63, issn 0028-3878, 4 p., SUPLT2Conference Paper
1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in miceYOUNGSTER, S. K; DUVOISIN, R. C; HESS, A et al.European journal of pharmacology. 1986, Vol 122, Num 2, pp 283-287, issn 0014-2999Article
Biochemical mechanisms underlying MPTP-induced and idiopathic Parkinsonism : new vistasSINGER, T. P; RAMSAY, R. R; SONSALLA, P. K et al.Advances in neurology. 1993, Vol 60, pp 300-305, issn 0091-3952Article
MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in ratsSONSALLA, P. K; ZEEVALK, G. D; MANZINO, L et al.Journal of neurochemistry. 1992, Vol 58, Num 5, pp 1979-1982, issn 0022-3042Article
Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug-induced choreaSAGE, J. I; MARK, M. H; MCHALE, D. M et al.Annals of neurology. 1991, Vol 29, Num 6, pp 623-628, issn 0364-5134Article
1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studiesMANAYE, K. F; SONSALLA, P. K; BARNETT, G et al.Brain research. 1989, Vol 491, Num 2, pp 307-315, issn 0006-8993Article
Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2' Me-MPTPKINDT, M. V; YOUNGSTER, S. K; SONSALLA, P. K et al.European journal of pharmacology. 1988, Vol 146, Num 2-3, pp 313-318, issn 0014-2999Article
Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouseSONSALLA, P. K; YOUNGSTER, S. K; KINDT, M. V et al.The Journal of pharmacology and experimental therapeutics. 1987, Vol 242, Num 3, pp 850-857, issn 0022-3565Article
